Inventor
WALL G MICHAEL
US13 patents
⚠️ This page may combine multiple inventors who share the name “WALL G MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NACUITY PHARMACEUTICALS INC
7 patentsUS11548851B2Jan 10, 2023
Method for preparation of n-acetyl cysteine amide and derivatives thereof
NACUITY PHARMACEUTICALS INC3 citations68
US11091433B2Aug 17, 2021
Method for preparation of N-acetyl cysteine amide and derivatives thereof
NACUITY PHARMACEUTICALS INC4 citations68
US10590073B2Mar 17, 2020
Method for preparation of N-acetyl cysteine amide and derivatives thereof
NACUITY PHARMACEUTICALS INC5 citations68
US12458608B2Nov 4, 2025
N-Acetylcysteine Amide (NACA) and (2R,2R′)-3,3′ disulfanediyl BIS(2-acetamidopropanamide) (DINACA) for the prevention and treatment of radiation dermatitis and skin lightening, skin whitening and skin improvement
NACUITY PHARMACEUTICALS INC0 citations60
US12245998B2Mar 11, 2025
N-acetylcysteine amide (NACA) and (2R,2R′)-3,3′ disulfanediyl bis(2-acetamidopropanamide) (diNACA) for the prevention and treatment of radiation pneumonitis and treatment of pulmonary function in Cystic Fibrosis
NACUITY PHARMACEUTICALS INC0 citations60
US11766413B2Sep 26, 2023
Treatment of age-related macular degeneration, glaucoma, and diabetic retinopathy with n-acetylcysteine amide (NACA) or (2R,2R′)-3,3′-disulfanediyl BIS(2-acetamidopropanamide)(DiNACA)
NACUITY PHARMACEUTICALS INC0 citations60
US11753370B2Sep 12, 2023
Methods of making deuterium-enriched N-acetylcysteine amide (d-NACA) and (2R, 2R′)-3,3′-disulfanediyl bis(2-acetamidopropanamide) (diNACA) and using d-NACA and diNACA to treat diseases involving oxidative stress
NACUITY PHARMACEUTICALS INC0 citations60